§ EQUITY
USD

NVCT

NUVECTIS PHARMA INC
USD
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
71 increased/new, 12 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
BlackRock, Inc.764K0.0%−2%
VANGUARD CAPITAL MANAGEMENT LLC660Kn/an/a
IRIDIAN ASSET MANAGEMENT LLC/CT652K2.0%+11%
Occam Crest Management LP407K1.9%+7%
Geode Capital Management384K0.0%+6%
BALDWIN WEALTH PARTNERS LLC/MA379K0.2%−3%
◇ AC INTELLIGENCE

Top institutional owners for NVCT as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER64.3% · 33 holders
PASSIVE / INDEX23.4% · 6 holders
DEALER / BANK9.6% · 16 holders
TACTICAL / MACRO1.5% · 1 holder
SYSTEMATIC / QUANT0.6% · 2 holders
QUALITY / COMPOUNDER0.5% · 3 holders
INCOME / DEFENSIVE0.2% · 3 holders
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for NVCT in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention NVCT yet.